CIK 0001434868
ESPR Esperion Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Sep 18, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Signals
Open-market buys and sells at Esperion Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | Sheldon L. Koenig President and CEO sell | $79k 28,427 shares | -2% | - | |
| 30Weak | Benjamin Looker General Counsel sell | $18k 6,267 shares | -2% | - | |
| 37Weak | Benjamin Halladay Chief Financial Officer sell | $20k 7,046 shares | -1% | - | |
| 30Weak | Benjamin Halladay Chief Financial Officer sell | $12 11 shares | -0% | - | |
| 23Weak | Benjamin Looker General Counsel sell | $1,470 1,304 shares | -0% | - | |
| 37Weak | Benjamin Halladay Chief Financial Officer sell | $8,328 7,229 shares | -2% | - | |
| 46Moderate | Sheldon L. Koenig President and CEO sell | $34k 30,474 shares | -2% | - | |
| 30Weak | Benjamin Looker General Counsel sell | $7,398 6,422 shares | -2% | - | |
| 30Weak | Benjamin Halladay Chief Financial Officer sell | $8 8 shares | -0% | - | |
| 23Weak | Eric Warren Chief Commercial Officer sell | $106 108 shares | -0% | - | |
| 40Moderate | Sheldon L. Koenig President and CEO sell | $20k 13,047 shares | -1% | - | |
| 30Weak | Eric Warren Chief Commercial Officer sell | $3,618 2,433 shares | -1% | - | |
| 37Weak | Benjamin Halladay Chief Financial Officer sell | $5,242 3,535 shares | -1% | - | |
| 30Weak | Benjamin Halladay Chief Financial Officer sell | $20 11 shares | -0% | - | |
| 23Weak | Eric Warren Chief Commercial Officer sell | $446 239 shares | -0% | - | |
| 23Weak | Eric Warren Chief Commercial Officer sell | $278 123 shares | -0% | - | |
| 30Weak | Benjamin Halladay Chief Financial Officer sell | $20 9 shares | -0% | - | |
| 45Moderate | Sheldon L. Koenig President and CEO sell | $31k 12,447 shares | -2% | - | |
| 30Weak | Eric Warren Chief Commercial Officer sell | $5,426 2,234 shares | -1% | - | |
| 37Weak | Benjamin Halladay Chief Financial Officer sell | $7,866 3,245 shares | -1% | - | |
| 15Weak | Eric Warren Chief Commercial Officer sell | $427 197 shares | -0% | - | |
| 15Weak | Eric Warren Chief Commercial Officer sell | $227 107 shares | -0% | - |
Transactions
The last 44 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | Benjamin Looker General Counsel | SOpen-market sale Common Stock | -6,267 | $2.80 | $18k | 393,670 | Sep 18, 2025 |
| Sep 17, 2025 | Sheldon L. Koenig President and CEO | SOpen-market sale Common Stock | -28,427 | $2.79 | $79k | 1,518,831 | Sep 18, 2025 |
| Sep 17, 2025 | Benjamin Halladay Chief Financial Officer | SOpen-market sale Common Stock | -7,046 | $2.81 | $20k | 474,862 | Sep 18, 2025 |
| Jul 17, 2025 | Benjamin Halladay Chief Financial Officer | SOpen-market sale Common Stock | -11 | $1.12 | $12 | 474,462 | Jul 18, 2025 |
| Jul 17, 2025 | Benjamin Looker General Counsel | SOpen-market sale Common Stock | -1,304 | $1.13 | $1,470 | 399,937 | Jul 18, 2025 |
| Jul 1, 2025 | John Craig Thompson director | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jul 2, 2025 |
| Jun 17, 2025 | Benjamin Halladay Chief Financial Officer | SOpen-market sale Common Stock | -7,229 | $1.15 | $8,328 | 474,473 | Jun 18, 2025 |
| Jun 17, 2025 | Sheldon L. Koenig President and CEO | SOpen-market sale Common Stock | -30,474 | $1.11 | $34k | 1,541,488 | Jun 18, 2025 |
| Jun 17, 2025 | Benjamin Looker General Counsel | SOpen-market sale Common Stock | -6,422 | $1.15 | $7,398 | 401,241 | Jun 18, 2025 |
| May 29, 2025 | Nicole Vitullo director | AGrant or award Stock Option (right to buy)derivative | +88,000 | $0.00 | $0 | 88,000 | Jun 2, 2025 |
| May 29, 2025 | Seth H. Z. Fischer director | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 61,150 | Jun 2, 2025 |
| May 29, 2025 | Robert E. Hoffman director | AGrant or award Common Stock | +5,280 | $0.00 | $0 | 5,280 | Jun 2, 2025 |
| May 29, 2025 | Stephen Rocamboli director | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 69,261 | Jun 2, 2025 |
| May 29, 2025 | Jay Shepard director | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 84,599 | Jun 2, 2025 |
| May 29, 2025 | Tracy M Woody director | AGrant or award Stock Option (right to buy)derivative | +88,000 | $0.00 | $0 | 88,000 | Jun 2, 2025 |
| May 29, 2025 | J Martin Carroll director | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 97,650 | Jun 2, 2025 |
| May 29, 2025 | Jay Shepard director | AGrant or award Stock Option (right to buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 2, 2025 |
| May 29, 2025 | Stephen Rocamboli director | AGrant or award Stock Option (right to buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 2, 2025 |
| May 29, 2025 | J Martin Carroll director | AGrant or award Stock Option (right to buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 2, 2025 |
| May 29, 2025 | Robert E. Hoffman director | AGrant or award Stock Option (right to buy)derivative | +7,040 | $0.00 | $0 | 7,040 | Jun 2, 2025 |
| May 29, 2025 | Seth H. Z. Fischer director | AGrant or award Stock Option (right to buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Jun 2, 2025 |
| Apr 17, 2025 | Eric Warren Chief Commercial Officer | SOpen-market sale Common Stock | -108 | $0.98 | $106 | 370,218 | Apr 21, 2025 |
| Apr 17, 2025 | Benjamin Halladay Chief Financial Officer | SOpen-market sale Common Stock | -8 | $0.96 | $8 | 481,702 | Apr 21, 2025 |
| Apr 1, 2025 | Robert E. Hoffman director | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Apr 2, 2025 |
| Mar 18, 2025 | Sheldon L. Koenig President and CEO | SOpen-market sale Common Stock | -13,047 | $1.50 | $20k | 1,571,962 | Mar 19, 2025 |
| Mar 18, 2025 | Eric Warren Chief Commercial Officer | SOpen-market sale Common Stock | -2,433 | $1.49 | $3,618 | 370,326 | Mar 19, 2025 |
| Mar 18, 2025 | Benjamin Halladay Chief Financial Officer | SOpen-market sale Common Stock | -3,535 | $1.48 | $5,242 | 481,710 | Mar 19, 2025 |
| Mar 14, 2025 | Sheldon L. Koenig President and CEO | AGrant or award Common Stock | +840,000 | $0.00 | $0 | 1,585,009 | Mar 17, 2025 |
| Mar 14, 2025 | Benjamin Halladay Chief Financial Officer | AGrant or award Common Stock | +238,000 | $0.00 | $0 | 485,245 | Mar 17, 2025 |
| Mar 14, 2025 | Eric Warren Chief Commercial Officer | AGrant or award Common Stock | +213,000 | $0.00 | $0 | 372,759 | Mar 17, 2025 |
| Mar 14, 2025 | Benjamin Looker General Counsel | AGrant or award Common Stock | +224,000 | $0.00 | $0 | 407,663 | Mar 17, 2025 |
| Mar 14, 2025 | Eric Warren Chief Commercial Officer | AGrant or award Stock Option (right to buy)derivative | +191,000 | $0.00 | $0 | 191,000 | Mar 17, 2025 |
| Mar 14, 2025 | Benjamin Looker General Counsel | AGrant or award Stock Option (right to buy)derivative | +201,000 | $0.00 | $0 | 201,000 | Mar 17, 2025 |
| Mar 14, 2025 | Benjamin Halladay Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +213,000 | $0.00 | $0 | 213,000 | Mar 17, 2025 |
| Mar 14, 2025 | Sheldon L. Koenig President and CEO | AGrant or award Stock Option (right to buyderivative | +753,000 | $0.00 | $0 | 753,000 | Mar 17, 2025 |
| Feb 19, 2025 | Benjamin Halladay Chief Financial Officer | SOpen-market sale Common Stock | -11 | $1.86 | $20 | 240,671 | Feb 20, 2025 |
| Feb 19, 2025 | Eric Warren Chief Commercial Officer | SOpen-market sale Common Stock | -239 | $1.87 | $446 | 159,759 | Feb 20, 2025 |
| Jan 17, 2025 | Eric Warren Chief Commercial Officer | SOpen-market sale Common Stock | -123 | $2.26 | $278 | 159,998 | Jan 21, 2025 |
| Jan 17, 2025 | Benjamin Halladay Chief Financial Officer | SOpen-market sale Common Stock | -9 | $2.27 | $20 | 240,682 | Jan 21, 2025 |
| Dec 17, 2024 | Sheldon L. Koenig President and CEO | SOpen-market sale Common Stock | -12,447 | $2.47 | $31k | 739,819 | Dec 18, 2024 |
| Dec 17, 2024 | Eric Warren Chief Commercial Officer | SOpen-market sale Common Stock | -2,234 | $2.43 | $5,426 | 160,121 | Dec 18, 2024 |
| Dec 17, 2024 | Benjamin Halladay Chief Financial Officer | SOpen-market sale Common Stock | -3,245 | $2.42 | $7,866 | 240,691 | Dec 18, 2024 |
| Nov 19, 2024 | Eric Warren Chief Commercial Officer | SOpen-market sale Common Stock | -197 | $2.17 | $427 | 162,355 | Nov 20, 2024 |
| Oct 17, 2024 | Eric Warren Chief Commercial Officer | SOpen-market sale Common Stock | -107 | $2.12 | $227 | 162,552 | Oct 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- J Martin Carrolldirector
- Seth H. Z. Fischerdirector
- Benjamin HalladayChief Financial Officer
- Robert E. Hoffmandirector, cfo, officer
- Sheldon L. KoenigPresident and CEO
- Benjamin LookerGeneral Counsel
- Stephen Rocambolidirector
- Jay Sheparddirector
- John Craig Thompsondirector
- Nicole Vitullodirector
- Eric WarrenChief Commercial Officer
- Tracy M Woodydirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.